InsidersTradesSigma
Track the 에임드바이오 share price and the full insider trade history of the company, a listed equity based in South Korea. Shares are listed on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 에임드바이오 has published 16 insider filings. The latest transaction was reported on 5 February 2026 (Sale). Among the most active insiders: 인터베스트. Every trade is openly available.
16
Insider Decl.
n/a
Thresholds
n/a
12 ops.
Buy Volume
n/a
3 ops.
Sell Volume
16Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 5 February 2026
Declarations16 total
910,410 sharesKRXDART:20251222000374
10,590,823 sharesKRXDART:20251208000072
4,749,566 sharesKRXDART:20251205000210
16 of 16 declarations
关于 에임드바이오
AimdBio 是一家在健康和制药领域运营的公司，在 XKRX 市场上市。它专注于开发创新的生物制药解决方案。